These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 989131)

  • 1. Abnormal aminopyrine metabolism in patients with hepatic neoplasm. Detection by breath test.
    Hepner GW; Uhlin SR; Lipton A; Harvey HA; Rohrer V
    JAMA; 1976 Oct; 236(14):1587-90. PubMed ID: 989131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of hepatic function by breath analysis after oral administration of (14C)aminopyrine.
    Hepner GW; Vesell ES
    Ann Intern Med; 1975 Nov; 83(5):632-8. PubMed ID: 1200495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminopyrine disposition: studies on breath, saliva, and urine of normal subjects and patients with liver disease.
    Hepner GW; Vesell ES
    Clin Pharmacol Ther; 1976 Dec; 20(6):654-60. PubMed ID: 991536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial: Hepatic drug metabolism and malignancy.
    LaRusso NF
    JAMA; 1976 Oct; 236(14):1612-3. PubMed ID: 989139
    [No Abstract]   [Full Text] [Related]  

  • 5. A simple method for routine determination of the metabolic liver capacity: the aminopyrine breath test.
    Haustein KO; Schenker E
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):190-6. PubMed ID: 3922902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease.
    Schneider JF; Baker AL; Haines NW; Hatfield G; Boyer JL
    Gastroenterology; 1980 Dec; 79(6):1145-50. PubMed ID: 6777231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of liver function by the aminopyrine breath test.
    Villeneuve JP; Arsène D; Huet PM
    Clin Invest Med; 1983; 6(1):5-9. PubMed ID: 6403268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminopyrine metabolism in the presence of hyperbilirubinemia due to cholestasis or hepatocellular disease. Combined use of laboratory tests to study disease-induced alterations in drug disposition.
    Hepner GW; Vesell ES
    Clin Pharmacol Ther; 1977 May; 21(5):620-6. PubMed ID: 870274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of aminopyrine metabolism in man by breath analysis after oral administration of 14C-aminopyrine. Effects of phenobarbital, disulfiram and portal cirrhosis.
    Hepner GW; Vesell ES
    N Engl J Med; 1974 Dec; 291(26):1384-8. PubMed ID: 4427643
    [No Abstract]   [Full Text] [Related]  

  • 10. The relationship between aminopyrine breath test and severity of liver disease in cirrhosis.
    Morelli A; Narducci F; Pelli MA; Farroni F; Vedovelli A
    Am J Gastroenterol; 1981 Aug; 76(2):110-3. PubMed ID: 6795921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminopyrine breath test and zonal hepatic damage in rats.
    Farag MM; Volicer L
    Pharmacology; 1985; 31(6):309-17. PubMed ID: 3936064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The aminopyrine breath test.
    Perri F; Pastore M; Annese V; Andriulli A
    Ital J Gastroenterol; 1994; 26(6):306-17. PubMed ID: 7949268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited usefulness of the breath test in evaluation of drug metabolism: a study in human oral contraceptive users treated with dimethylaminoantipyrine and diazepam.
    Sonnenberg A; Koelz HR; Herz R; Benes I; Blum AL
    Hepatogastroenterology; 1980 Apr; 27(2):104-8. PubMed ID: 6783497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of drug metabolism in hepatic disease: comparison of plasma kinetics of oral cyclobarbital and the intravenous aminopyrine breath test.
    Breyer-Pfaff U; Seyfert H; Weber M; Egberts EH
    Eur J Clin Pharmacol; 1984; 26(1):95-101. PubMed ID: 6143671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.
    Fasoli A; Giannini E; Botta F; Romagnoli P; Risso D; Celle G; Testa R
    Hepatogastroenterology; 2000; 47(31):234-8. PubMed ID: 10690614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of hepatic tetrahydrofolate and inhibition of exhalation of 14CO2 formed from [dimethylamino-14C]aminopyrine in nitrous oxide-treated rats.
    Black KA; Virayotha V; Tephly TR
    Hepatology; 1984; 4(5):871-6. PubMed ID: 6434391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].
    von Mandach U; Jost G; Preisig R
    Schweiz Med Wochenschr; 1985 May; 115(19):651-8. PubMed ID: 3923620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of interference by sorbitol with aminopyrine breath test.
    Ramin VC; Bircher J
    Eur J Clin Pharmacol; 1990; 38(1):87-9. PubMed ID: 2109699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive diagnosis and prognosis of liver cirrhosis: a comparison of biological scores, elastometry, and metabolic liver function tests.
    Forestier J; Dumortier J; Guillaud O; Ecochard M; Roman S; Boillot O; Lutringer D; Scoazec JY; Subtil F; Mion F
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):532-40. PubMed ID: 20164779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14C-D-galactose breath test for evaluation of liver function in patients with chronic liver disease.
    Caspary WF; Schäffer J
    Digestion; 1978; 17(5):410-8. PubMed ID: 680418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.